1 / 51

Dietetic Management of Short Bowel Syndrome

Dietetic Management of Short Bowel Syndrome. Ali Singer Gastroenterology Specialist Dietitian Frenchay Hospital. Content. Definition Physiology Management Case Study. Definition.

maeko
Télécharger la présentation

Dietetic Management of Short Bowel Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dietetic Management of Short Bowel Syndrome Ali Singer Gastroenterology Specialist Dietitian Frenchay Hospital

  2. Content • Definition • Physiology • Management • Case Study

  3. Definition • The reduction of functioning gut mass to below the minimum necessary for the absorption of nutrients and/or water and electrolytesFleming & Remington, 1981

  4. Variability in Intestinal Lengths • Small intestinal length at autopsy: • 3-8.5m Bryant, 1924 • Shorter in women • SBS more common in women (67%) • Small intestinal length at laparotomy: n mean (cm) range (cm) Cook, 1974 6 421 320-521 Backman, 1974 32 643 400-846 Slater, 1991 38 500 302-782

  5. Record of Intestinal Length • Length removed often recorded • Length remaining is more important: • Laparotomy • SB contrast studies (less accurate) • Nutritional/fluid supplements needed if < 200cm SB

  6. Commonest causes: • Crohns • Superior mesenteric • artery thrombosis • Irradiation Causes of SBS

  7. SBS: Anatomy • Mid-SB resection: • Uncommon • Rarely problems • Jejunocolic anastomosis: • Usually fluid balance maintained • Nutritional issues when SB <100cm • Jejunostomy/high output enterocutaneous fistula: • Large stoma/fistula water and sodium losses • Dehydration • +/- nutritional problems

  8. Types of Short Bowel

  9. Jejunum Na+/H2O secretion 1st 100cm Leaky Na+ absorption Small conc. gradient only Dependent on H2O movement Coupled to gluc/AA absorption Maximal Na+ absorption when [Na+] 120mmol/l Ileum Active Na+/H2O absorption Less leaky Na+ absorption Large conc. gradient Not dependent on H2O movement Not coupled to gluc/AA absorption Increased by Aldosterone Normal GI Physiology

  10. Normal GI Physiology

  11. Jejunal-colon: NORMAL Jejunostomy: FAST Gastrointestinal Motility Peptide YY and GLP-2 (glucagon-like peptide 2) are released when food passes the terminal ileum and caecum that act as ileal and colonic braking mechanisms; this is lost in jejunostomy

  12. Physiological Consequences • Increased gastric emptying • Increased SB transit • Increased gastric secretions (first 2 wks) • Resection of ileal & colonic braking mechanism • Changes in GI hormones • Reduced peptide YY, glucagon like peptide 2 • Increased gastrin

  13. Critical Lengths

  14. Nutritional Support and Bowel Length

  15. <200cm: restrict oral hypotonic fluids, sip glucose - saline supplement (100mmol/L Na, like jejunostomy fluid) • <100cm: parenteral saline • <50cm: parenteral nutrition and saline

  16. GI Secretions Jejunum – colon • Reabsorb unabsorbed fluid in colon Jejunostomy • Salt and water loss from stoma • <100cm jejunum: losses > oral intake • Rapid sodium fluxes occur in jejunum • If water/solutions of <90mmol/L sodium are drunk a net efflux of sodium into the bowel lumen occurs until 100mmol/L is reached

  17. Absorptive Functions B12 and fat malabsorption occur if >60-100cm terminal ileum resected • Increased hepatic synthesis of bile salts cannot compensate; unabsorbed bile salts contribute to colonic secretion Magnesium deficiency • Chelation of unabsorbed fatty acids reduces absorption • Increased renal excretion; secondary hypoaldosteronism

  18. Hypomagnesaemia

  19. Clinical Picture

  20. Adaptive Processes • Hyperphagia; increased food intake • Structural adaption: • increasing absorptive area • Functional adaption; • slowing gastrointestinal transit (gastric emptying and small bowel transit) • Occurs in jejunum-colon patients due to high peptide YY and GLP-2, leads to increased jejunal absorption of macronutrients (glucose, water, Na, Ca) and overtime may no longer need TPN

  21. Jejunum-Colon Pts Post resection: • Parenteral fluids and nutrition (helps surgical repair, ileus recovery and avoids deficiencies) • 6/12 PPI • Multivitamin Long term: • Undernutrition • Diarrhoea due to malabsorption • Vitamin/mineral deficiency

  22. Undernutrition • >50% of energy from diet malabsorbed • High energy foods, sip feeds +/- NG/PEG feed; if fails TPN. Improves over time. • Long term TPN: • Absorption of <33% oral energy intake • Absorption 30-60%, high energy requirements • Large volume stomal output / diarrhoea • High carbohydrate, normal fat, low oxalate diet • Topical sunflower oil for essential fatty acids

  23. The Fat Dilemma But high carbohydrate without fat is unpalatable and fat yields twice as much energy as carbohydrate; also a low fat diet risks essential fatty acid deficiency.

  24. Common: B12 deficiency; replace Selenium deficiency; replace Magnesium deficiency; replace if occurs Vitamins D, E, A, K and essential fatty acids; replace Rare: Potassium deficiency Zinc deficiency; rare unless large stool volumes Water and sodium; rare as absorbed well in colon, if occurs sips of glucose saline drink Deficiencies

  25. Other complications Diarrhoea • Limit food intake • Consider loperamide 2-8mg 30mins pre meals, codeine 30-60mg 30mins pre meals • If >100cm terminal ileum resected cholestyramine for bile salt malabsorption and reduced oxalate absorption Confusion • Hypomagnesaemia, thiamine deficiency, lactic acidosis (restrict mono / oligo saccharides) and hyperammonaemia (inadequate citrulline manufacture, Tx is arginine)

  26. Drug absorption • warfarin, digoxin, thyroxine, loperamide and if <50cm jejunum omeprazole may not be absorbed Gallstones(calcium bilirubinate stones) • Bilary stasis. Therefore occurs in 45%, especially men • Tx IV amino acids, enteral feed, cholecystokinin injections, NSAIDS, ursodeoxycholicacid, metronidazole, cholecystectomy Renal stones(calcium oxalate stones/nephrocalcinosis/CRF) • Occurs in 25% largely due to increased colonic absorption of oxalate Social

  27. Ca Oxalate Renal Stones

  28. Jejunostomy Patient Issues • Salt and water depletion • May be large volume of stomal output • Greater volume lost after food or fluids • GI secretion  4L/day, majority absorbed in jejunum therefore more fluid losses via stoma if short jejunum • Jejunostomy fluid contains 100mmol/L Na, 15mmol/L K • If given hypotonic fluids  100mmol/L the mucosa allows leaking of fluid and electrolytes into the lumen • Low sodium levels are NOT SIADH but sodium depletion, this is resolved when urine Na  30mmol

  29. Jejunostomy Patient Issues • Hypokalemia • Rare, occurs when <50cm jejunum • Usually due to secondary hypoaldersteronism from Na depletion • Can be due to hypomagnesaemia causing potassium channel dysfunction and increased renal potassium secretion which responds to Mg not K supplements • Hypomagnesaemia • B12 deficiency, confusion, drug absorption, and gall stones • Nutritional

  30. High Output Jejunostomy • Exclude other causes of a high output • Stage1: Establish stability • Stage 2: Establish oral intake • Introduce enteral food/fluid/feed • Stage 3: Rehabilitation • Stoma care, HPN training, social issues • Stage 4: Long term care

  31. Other Causes • Intra-abdominal sepsis • Partial/intermittent bowel obstruction • Enteritis (clostridium, salmonella) • Recurrent disease in remaining bowel (Crohn’s, irradiation) • Bacterial overgrowth • Suddenly stopping drugs (steroids, opiates) • Giving prokinetics (metoclopramide) • Coeliac • Hyperthyroidism

  32. Stage 1: Establish Stability • Severe dehydration & Na+ depletion • Keep patient NBM • IV normal saline (2-6L/day)

  33. Treat the Cause • Intraabdominal sepsis / abscess • Partial / intermittent bowel obstruction • Strictures; placement / muscle tunnel / adhesions / crohns / ischaemic fibrosis / radiotherapy • Enteritis; clostridium / salmonella / rota virus • Recurrent disease; Crohns / irradiation • Sudden stopping of drugs; steroids / opiates • Drugs; prokinetics / metoclopramide / metformin / PPI / statin • Diet; lactose intolerant / coeliac

  34. Stage 2: Establish Oral Intake • Restrict oral fluids to <500ml/day • Hypotonic (water, tea, coffee, squash, alcohol) • Hypertonic (fruit juices, coca cola, sip feeds) • Drink a glucose-saline solution <500ml/day

  35. Na+ and H2O Hypotonic Fluids 0 mmol Na+ High Output 100 mmol/L Na • Leaky • Small conc. gradient only • Dependent on H2O movement Na 140 mmol/L jejunum Unable to maintain Na gradient Electrolyte Mix 90 mmol Na+/L Smaller volume 100mmol/L Na+ Na+ 140 mmol/L

  36. Oral Rehydration Therapy

  37. Recipe: ORS • 20g (6 teaspoons) glucose • 3.5g (1 level 5ml teaspoon) salt • 2.5g (1 heaped 2.5ml spoon) sodium bicarbonate • 1L water • Add cordial, chill and drink through a straw

  38. Antisecretory: Omeprazole; decreases gastric acid secretion Ranitidine/cimetidine Octreotide; decreases intestinal secretions Antimotility: Loperamide upto 64mg PO o.d asdecreased enterohepatic circulation Codeine Lomotil Drug Therapy • Vit/min supplements: • B12, selenium, Mg2+, vit A, D, E, K

  39. Parenteral Therapy • 0.5–1L saline sc +/- 4mmol MgSO4 1-3/week • 1L saline IV +/- 4-12 mmol MgSO4 > 3/ week • IVN

  40. Outcome Aims • Clinical: • No thirst or signs of dehydration • Acceptable strength, energy and appearance • Measures: • Gut loss <2L/day • Urine volume >800ml/day • Urinary Na+>20 mmol/L • Normal serum Na+, Mg2+ and K+ • Body weight within 10% of normal

  41. Stage 3: Rehabilitation • Transfer to IF unit • Wound healing • Stoma care • HPN training • 1st patient 1978 • Longest 27 years • Mean age 50.2 years (19.9 – 76.9) • ~27 new patients per year per unit • Social issues

  42. Stage 4: Long-Term Care • 3 monthly multidisciplinary clinics • IF unit • Shared care with local hospital

  43. Outcome 1 year after starting HPN (467 patients) BANS 1996-2000

  44. Mr J: background information • 72 male  UC (1961) • Pan-protocolectomy (1962) • Refashioned/Re-sited Ileostomy (1993) • s/b Dr Kaskey, Renal Physician 2º renal impairment and kidney stones • Referred from renal dietetic clinic (pt initially attempted to resist a referral!)

  45. High output ileostomy output (estimated up to 2.5L per day) Issues Dehydration ( UO,  urine Na) Renal impairment & stone formation

  46. Assessment: Concerns • Renal impairment: * stage 4 CKD • Poor seal on stoma bags • Not leaving house when stoma active

  47. Intervention

  48. Outcomes • Outcome measures • Biochemistry:

  49. Outcomes • Reduction in stoma output •  from ~ 2.5 L to < 1L /d • Thickened output (watery  porridge-like consistency) • Pt satisfaction • Practicalities in day-to-day management of stoma • Follow-up • Sole Dietetic f/u • Renal physician’s happy with progress

More Related